Mira Pharmaceuticals (MIRA) Total Debt (2022 - 2023)
Mira Pharmaceuticals (MIRA) posted Total Debt of $1.8 million for Q2 2023, up 1254.99% sequentially from $133062.0 in Q4 2022.
Mira Pharmaceuticals (MIRA) Total Debt (2022 - 2023) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 2 years of Total Debt data on file, last reported at $1.8 million in Q2 2023.
- Quarterly Total Debt changed N/A year-over-year to $1.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.8 million (changed N/A YoY) and the FY2022 annual result came in at $133062.0, changed N/A from the prior year.
- Total Debt climbed to $1.8 million in Q2 2023 per MIRA's latest filing, from $133062.0 in the prior quarter.
- The five-year high for Total Debt was $1.8 million in Q2 2023, with the low at $133062.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 43.37 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 54.99 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 64.53 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -24.45 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 49.12 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 57.32 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 22.17 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 64.46 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.80 Mn |
| Dec 31, 2022 | 133,062.00 |